Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

PNR Pentair Inc

81,38

2,05 (2,58%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Pentair (NYSE:PNR)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Pentair Charts.

Pentair (NYSE:PNR)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Pentair Charts.

News Pentair Inc

Form SD - Specialized disclosure report
Mittwoch 29 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Pentair to Attend Upcoming Investor Conferences
Donnerstag 23 Mai 2024 (1 Woche vor) • Business Wire

Form 144 - Report of proposed sale of securities
Mittwoch 22 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Pentair Pool Announces Partnership of the 2026 Special Olympics USA Games
Freitag 17 Mai 2024 (2 Wochen vor) • Business Wire

Form 8-K - Current report
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Pentair Announces Quarterly Cash Dividend of $0.23
Montag 6 Mai 2024 (4 Wochen vor) • Business Wire

Pentair Reports Strong First Quarter 2024 Results
Dienstag 23 April 2024 (1 Monat vor) • Business Wire

Making Better Essential: Pentair Releases 2023 Corporate Responsibility Report Featuring Its Progress in Advancing Sustainability
Donnerstag 18 April 2024 (1 Monat vor) • Business Wire

Pentair to Release First Quarter 2024 Earnings and Host Investor Conference Call on April 23
Dienstag 9 April 2024 (2 Monate vor) • Business Wire

Pentair Earns 2024 ENERGY STAR® Partner of the Year – Sustained Excellence Award
Dienstag 26 März 2024 (2 Monate vor) • Business Wire

Pentair to Present at J.P. Morgan Investor Conference
Montag 11 März 2024 (3 Monate vor) • Business Wire

Weitere Pentair Inc News-Artikel

Avalo Therapeutics

BPCE Home Loans Fct 2018...

Digital World Leaders Op...

Vaneck Office and Commer...

Pieris Pharmaceuticals

Dividend Growers and Tax...

Diversified High Income ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen